Objective The therapeutic efficacy of anterior thalamic nuclei
deep brain stimulation (ATN-DBS) against
seizures has been largely accepted; however, the effects of ATN-DBS on disruption of the blood-brain barrier (BBB),
albumin extravasation,
inflammation and apoptosis still remain unclear. Methods Rats were distributed into four treatment groups: physiological saline (PS, N = 12),
kainic acid (KA, N = 12), KA-
sham-DBS (N = 12) and KA-DBS (N = 12).
Seizures were monitored using video-electroencephalogram (EEG). One day after surgery, all rats were sacrificed. Then, samples were prepared for quantitative real-time PCR (qPCR), western blot, immunofluorescence (IF) staining, and transmission electron microscopy to evaluate the disruption of the BBB,
albumin extravasation,
inflammation, and apoptosis. Result Because of the KA injection, the disruption of the BBB,
albumin extravasation,
inflammation and apoptosis were more severe in the KA and the KA-
sham-DBS groups compared to the PS group (all Ps < 0.05 or < 0.01). The ideal outcomes were observed in the KA-DBS group. ATN-DBS produced a 46.3% reduction in seizure frequency and alleviated the disruption of the BBB,
albumin extravasation, inflammatory reaction and apoptosis in comparison to the KA-
sham-DBS group (all Ps < 0.05 or < 0.01). Conclusion (1)
Seizures can be reduced using ATN-DBS in the epileptogenic stage. (2) ATN-DBS can reduce the disruption of the BBB and
albumin extravasation. (3) ATN-DBS has an anti-inflammatory effect in epileptic models.